Published on April 13th, 2022 | by University of Mississippi


University of Mississippi Engineer Receives NSF Award to Help Develop Better Immunotherapies

Prestigious award for Thomas Werfel supports studies into targeted vaccines and cancer treatments

Thomas Werfel, assistant professor of biomedical engineering at the University of Mississippi, has received a Faculty Early Career Development, or CAREER, award from the National Science Foundation.

The CAREER award, a five-year grant for $597,638, will fund Werfel’s efforts to create innovative biomaterials that will help human immune systems respond better to illnesses.

The immune system is one of the most complex systems in the body: molecules, cells and organs work together to keep a person healthy. It responds to all types of challenges – such as infections, cancers and toxins – with great precision in terms of timing and location.

Immunotherapies – drugs that harness the power of the immune system – are typically given all at once as single therapies. That means they often lack the level of precision needed in terms of where, how much and how long the drug is administered.

Werfel’s research seeks to radically improve the ability to program immune responses by developing biomaterials that can recruit, train and sustain relevant immune cells with greater accuracy.

Ultimately, this could result in vaccines and cancer treatments that maximize the effectiveness of the immune response.

“We think our approach has great potential because it is based on the way the body naturally responds to infection, as opposed to traditional approaches to drug-making,” said Werfel.

“To achieve this, it is necessary to pursue new technologies that can perform in this novel manner. I’m truly honored to receive the NSF CAREER award, as it allows me the time and resources to hopefully discover a way to improve health care for many Americans.”

Werfel also has received a nearly $800,000 grant from the American Cancer Society in a complementary area: research into new treatments for metastatic breast cancer.

As part of his CAREER grant, Werfel plans to set up a Nanoengineering Research Experience for Undergraduates, with particular focus on underrepresented students from Mississippi and nearby. The summer program would provide research and professional development opportunities.

He also wants to establish a STEM Excursion program, where north Mississippi high school students can learn about nanobiotechnology from Ole Miss undergraduate researchers.

Werfel explained that “these outreach efforts provide a great opportunity for students of all backgrounds to learn about this exciting new field. And, this gives our young academics the possibility to share their passion and gain mentoring skills.”

The NSF’s Faculty Early Career Development program supports early-career faculty who have the potential to serve as academic role models in research and education and to lead advances in the mission of their department or organization.

This prestigious award is designed to help early-career faculty build a firm foundation for a lifetime of leadership in integrating education and research.

Several UM researchers have received NSF CAREER Awards, but this is the first for the School of Engineering.

“I am pleased that Thomas’ work has been recognized with this great honor,” said Dave Puleo, dean of the School of Engineering. “This is an excellent moment for the school and it demonstrates our efforts to give cutting-edge research opportunities to our students.”

The project, titled “Multimodal biomaterials for sequential delivery of diverse immunotherapeutic cargos,” is jointly funded by the NSF’s Biomaterials program and the Established Program to Stimulate Competitive Research. EPSCoR works to enhance the research competitiveness of certain jurisdictions, such as underfunded states, by strengthening STEM capacity and capability.

By Lou Tyson

Thomas Werfel, assistant professor of biomedical engineering at the University of Mississippi, has received a five-year grant to fund his efforts to create innovative biomaterials that will help human immune systems respond better to illnesses. Photo by Thomas Graning/Ole Miss Digital Imaging Services
In this image, cancer cells are being used to test investigational new drugs. The green is staining a target in the cells that causes cancer cells to grow, and the drug being delivered to the cells shows up as red. University of Mississippi biomedical engineer Thomas Werfel is working to develop biomaterials that can harness human immune cells to improve the accuracy and effectiveness of vaccines and cancer treatments. Submitted photo
"The Anthropocene Reviewed" Selected as 2022 Common Read at Ole Miss
Delta Conservation Topic for Hybrid Oxford Science Cafe

Tags: , , , , , , , ,

About the Author

The University of Mississippi, affectionately known as Ole Miss, is Mississippi’s flagship university. A member of the elite group of R1: Doctoral Universities - Highest Research Activity by the Carnegie Classification, Ole Miss has a long history of producing leaders in public service, business, academics and the professions. Its 16 academic divisions include a major medical school; nationally recognized schools of accountancy, law and pharmacy; and an Honors College acclaimed for a blend of academic rigor, experiential learning and opportunities for community action. Acclaimed as one of the nation’s most beautiful, Ole Miss's main campus is in Oxford, which is routinely recognized as one of the nation's best college towns.

Leave a Reply

Back to Top ↑